|
⚲
|
| Keyboard |
| Atkisson Erik
✚
|
|
|---|---|
| CIK # | 0001885915 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001885915] | |
| 4 | [0001885915] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Achieve Life Sciences Inc | |
| Atkisson Erik | |
| Rain Oncology Inc | |
| Celladon Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Achieve Life Sciences Inc ACHV
Stock Option (right to buy) · derivative
|
2025-12-04 | Grant | 250,000 | $0.00 | |
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2024-01-26 | Disposed to issuer | 60,251 | ||
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2024-01-26 | Disposed to issuer | 82,882 | ||
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2024-01-26 | Disposed to issuer | 37,118 | ||
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2023-08-09 | Grant | 60,251 | $0.00 | |
|
Rain Oncology Inc RAIN
Stock Option (Right to Buy) · derivative
|
2023-03-02 | Grant | 120,000 | $0.00 | |
|
Celladon Corp EIGR
Stock Option (Right to Buy) · derivative
|
2023-01-26 | Grant | 26,750 | $0.00 | |
|
Celladon Corp EIGR
Stock Option (Right to Buy) · derivative
|
2022-03-11 | Grant | 38,000 | $0.00 | |
|
Celladon Corp EIGR
Common Stock
|
2022-03-11 | Grant | 6,000 | $0.00 | |
|
Celladon Corp EIGR
Stock Option (Right to Buy) · derivative
|
2021-09-30 | Grant | 180,000 | $0.00 |